UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

miR-34 - a microRNA replacement therapy is headed to the clinic

Frontiers in genetics, 2012, Vol.3, p.120-120

Bader, Andreas G

2012

Volltextzugriff (PDF)

The Promise of MicroRNA Replacement Therapy

Cancer research (Chicago, Ill.), 2010-09, Vol.70 (18), p.7027-7030

2010

Volltextzugriff (PDF)

Development of a Lung Cancer Therapeutic Based on the Tumor Suppressor MicroRNA-34

Cancer research (Chicago, Ill.), 2010-07, Vol.70 (14), p.5923-5930

2010

Volltextzugriff (PDF)

The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44

Nature medicine, 2011-02, Vol.17 (2), p.211-215

2011

Volltextzugriff (PDF)

In-depth analysis shows synergy between erlotinib and miR-34a

PloS one, 2014-02, Vol.9 (2), p.e89105-e89105

2014

Volltextzugriff (PDF)

Systemic Delivery of Tumor Suppressor microRNA Mimics Using a Neutral Lipid Emulsion Inhibits Lung Tumors in Mice

Molecular therapy, 2011-06, Vol.19 (6), p.1116-1122

2011

Volltextzugriff (PDF)

Systemic Delivery of Synthetic MicroRNA-16 Inhibits the Growth of Metastatic Prostate Tumors via Downregulation of Multiple Cell-cycle Genes

Molecular therapy, 2010-01, Vol.18 (1), p.181-187

2010

Volltextzugriff (PDF)

Phosphatidylinositol 3-Kinase Mutations Identified in Human Cancer Are Oncogenic

Proceedings of the National Academy of Sciences - PNAS, 2005-01, Vol.102 (3), p.802-807

2005

Volltextzugriff (PDF)

Therapeutic Delivery of miR-200c Enhances Radiosensitivity in Lung Cancer

Molecular therapy, 2014-08, Vol.22 (8), p.1494-1503

2014

Volltextzugriff (PDF)

The let-7 microRNA reduces tumor growth in mouse models of lung cancer

Cell cycle (Georgetown, Tex.), 2008-03, Vol.7 (6), p.759-764

2008

Volltextzugriff (PDF)

Cancer-Specific Mutations in PIK3CA Are Oncogenic in vivo

Proceedings of the National Academy of Sciences - PNAS, 2006-01, Vol.103 (5), p.1475-1479

2006

Volltextzugriff (PDF)

Quantification of Therapeutic miRNA Mimics in Whole Blood from Nonhuman Primates

Analytical chemistry (Washington), 2014-02, Vol.86 (3), p.1534-1542

2014

Volltextzugriff (PDF)

In Vivo Delivery of miR-34a Sensitizes Lung Tumors to Radiation Through RAD51 Regulation

Molecular therapy. Nucleic acids, 2015-12, Vol.4 (12), p.e270-e270, Article e270

2015

Volltextzugriff (PDF)

Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors

Investigational new drugs, 2017-04, Vol.35 (2), p.180-188

2017

Volltextzugriff (PDF)

Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours

British journal of cancer, 2020-05, Vol.122 (11), p.1630-1637

2020

Volltextzugriff (PDF)

PDL1 Regulation by p53 via miR-34

JNCI : Journal of the National Cancer Institute, 2016-01, Vol.108 (1), p.1

2016

Volltextzugriff (PDF)

Inhibition of Protein Synthesis by Y Box-Binding Protein 1 Blocks Oncogenic Cell Transformation

Molecular and Cellular Biology, 2005-03, Vol.25 (6), p.2095-2106

2005

Volltextzugriff (PDF)

Oncogenic PI3K deregulates transcription and translation

Nature reviews. Cancer, 2005-12, Vol.5 (12), p.921-929

2005

Volltextzugriff (PDF)

TP53-independent function of miR-34a via HDAC1 and p21(CIP1/WAF1.)

Molecular therapy, 2013-09, Vol.21 (9), p.1678-1686

2013

Volltextzugriff (PDF)

Synergy between next generation EGFR tyrosine kinase inhibitors and miR–34a in the inhibition of non-small-cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2017-06, Vol.108, p.96-102

2017

Volltextzugriff (PDF)

Evaluating Synergistic Effects of miR-34a Mimics in Combination with Other Therapeutic Agents in Cultured Non-Small Cell Lung Cancer Cells

Methods in molecular biology (Clifton, N.J.), 2017, Vol.1517, p.115

2017

Volltextzugriff (PDF)

Mutated PI 3-Kinases: Cancer Targets on a Silver Platter

Cell cycle (Georgetown, Tex.), 2005-04, Vol.4 (4), p.571-574

2005

Volltextzugriff (PDF)

miR-888: Hit it when you see it

Cell cycle (Georgetown, Tex.), 2014-02, Vol.13 (3), p.351-351

Bader, Andreas

2014

Volltextzugriff (PDF)

Abstract 4829: miRNA combination therapy: In vitro anticancer synergy between miR-34a mimic and cytotoxic chemotherapy (CT) in NSCLC

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.4829-4829

2016

Volltextzugriff (PDF)

Y Box-Binding Protein 1 Induces Resistance to Oncogenic Transformation by the Phosphatidylinositol 3-Kinase Pathway

Proceedings of the National Academy of Sciences - PNAS, 2003-10, Vol.100 (21), p.12384-12389

2003

Volltextzugriff (PDF)

1 – 25 von 117

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(105)
Mit Volltextzugriff
(99)

Publikationsform

Sprache

Englisch
(115)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(76)
Life Sciences & Biomedicine
(62)
Humans
(57)
Animals
(34)
Male
(25)
Female
(21)
Oncology
(19)
Mice
(16)
Adult
(14)
Cell Biology
(14)
Tumors
(14)
Middle Aged
(13)
Mutation
(13)
Biological And Medical Sciences
(12)
Genetics & Heredity
(12)
Biochemistry & Molecular Biology
(11)
Cell Line, Tumor
(11)
Proteins
(11)
Science & Technology - Other Topics
(10)
Aged
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

miR-34 - a microRNA replacement therapy is headed to the clinic

The Promise of MicroRNA Replacement Therapy

Development of a Lung Cancer Therapeutic Based on the Tumor Suppressor MicroRNA-34

The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44

In-depth analysis shows synergy between erlotinib and miR-34a

Systemic Delivery of Tumor Suppressor microRNA Mimics Using a Neutral Lipid Emulsion Inhibits Lung Tumors in Mice

Systemic Delivery of Synthetic MicroRNA-16 Inhibits the Growth of Metastatic Prostate Tumors via Downregulation of Multiple Cell-cycle Genes

Phosphatidylinositol 3-Kinase Mutations Identified in Human Cancer Are Oncogenic

Therapeutic Delivery of miR-200c Enhances Radiosensitivity in Lung Cancer

The let-7 microRNA reduces tumor growth in mouse models of lung cancer

Cancer-Specific Mutations in PIK3CA Are Oncogenic in vivo

Quantification of Therapeutic miRNA Mimics in Whole Blood from Nonhuman Primates

In Vivo Delivery of miR-34a Sensitizes Lung Tumors to Radiation Through RAD51 Regulation

Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors

Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours

PDL1 Regulation by p53 via miR-34

Inhibition of Protein Synthesis by Y Box-Binding Protein 1 Blocks Oncogenic Cell Transformation

Oncogenic PI3K deregulates transcription and translation

TP53-independent function of miR-34a via HDAC1 and p21(CIP1/WAF1.)

Synergy between next generation EGFR tyrosine kinase inhibitors and miR–34a in the inhibition of non-small-cell lung cancer

Evaluating Synergistic Effects of miR-34a Mimics in Combination with Other Therapeutic Agents in Cultured Non-Small Cell Lung Cancer Cells

Mutated PI 3-Kinases: Cancer Targets on a Silver Platter

miR-888: Hit it when you see it

Abstract 4829: miRNA combination therapy: In vitro anticancer synergy between miR-34a mimic and cytotoxic chemotherapy (CT) in NSCLC

Y Box-Binding Protein 1 Induces Resistance to Oncogenic Transformation by the Phosphatidylinositol 3-Kinase Pathway

Suchergebnisse filtern